71 related articles for article (PubMed ID: 7629594)
1. Tissue perfusion of copper-62-PTSM: relevance of studies in animal models as predictors of clinical radiopharmaceutical performance.
Fritzberg AR
J Nucl Med; 1995 Aug; 36(8):1456-7. PubMed ID: 7629594
[No Abstract] [Full Text] [Related]
2. Human biodistribution and dosimetry of the PET perfusion agent copper-62-PTSM.
Wallhaus TR; Lacy J; Whang J; Green MA; Nickles RJ; Stone CK
J Nucl Med; 1998 Nov; 39(11):1958-64. PubMed ID: 9829589
[TBL] [Abstract][Full Text] [Related]
3. Species-dependent binding of copper(II) bis(thiosemicarbazone) radiopharmaceuticals to serum albumin.
Mathias CJ; Bergmann SR; Green MA
J Nucl Med; 1995 Aug; 36(8):1451-5. PubMed ID: 7629593
[TBL] [Abstract][Full Text] [Related]
4. Tissue blood flow estimation with copper(II)-pyruvaldehyde bis (N-4-methylthiosemicarbazone) and PET.
Young H; Carnochan P; Zweit J; Babich J; Cherry S; Ott R
J Nucl Biol Med (1991); 1994 Dec; 38(4 Suppl 1):89-91. PubMed ID: 7632775
[TBL] [Abstract][Full Text] [Related]
5. Preclinical studies of [61Cu]ATSM as a PET radiopharmaceutical for fibrosarcoma imaging.
Jalilian AR; Rostampour N; Rowshanfarzad P; Shafaii K; Kamali-Dehghan M; Akhlaghi M
Acta Pharm; 2009 Mar; 59(1):45-55. PubMed ID: 19304557
[TBL] [Abstract][Full Text] [Related]
6. The potential role of generator-produced radiopharmaceuticals in clinical PET.
Welch MJ; McCarthy TJ
J Nucl Med; 2000 Feb; 41(2):315-7. PubMed ID: 10688117
[No Abstract] [Full Text] [Related]
7. Regional myocardial perfusion assessed with generator-produced copper-62-PTSM and PET.
Herrero P; Hartman JJ; Green MA; Anderson CJ; Welch MJ; Markham J; Bergmann SR
J Nucl Med; 1996 Aug; 37(8):1294-300. PubMed ID: 8708759
[TBL] [Abstract][Full Text] [Related]
8. Species dependence of [64Cu]Cu-Bis(thiosemicarbazone) radiopharmaceutical binding to serum albumins.
Basken NE; Mathias CJ; Lipka AE; Green MA
Nucl Med Biol; 2008 Apr; 35(3):281-6. PubMed ID: 18355683
[TBL] [Abstract][Full Text] [Related]
9. The kinetics of copper-62-PTSM in the normal human heart.
Beanlands RS; Muzik O; Mintun M; Mangner T; Lee K; Petry N; Hutchins GD; Schwaiger M
J Nucl Med; 1992 May; 33(5):684-90. PubMed ID: 1569476
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of Cu-PTSM as a tracer of tumor perfusion: comparison with labeled microspheres in spontaneous canine neoplasms.
Mathias CJ; Green MA; Morrison WB; Knapp DW
Nucl Med Biol; 1994 Jan; 21(1):83-7. PubMed ID: 9234268
[TBL] [Abstract][Full Text] [Related]
11. Elucidation of the human serum albumin (HSA) binding site for the Cu-PTSM and Cu-ATSM radiopharmaceuticals.
Basken NE; Mathias CJ; Green MA
J Pharm Sci; 2009 Jun; 98(6):2170-9. PubMed ID: 18937368
[TBL] [Abstract][Full Text] [Related]
12. The effects of glutathione depletion on the biodistribution of Cu(PTSM) in rats.
Barnhart-Bott A; Green MA
Int J Rad Appl Instrum B; 1991; 18(8):865-9. PubMed ID: 1800462
[TBL] [Abstract][Full Text] [Related]
13. Mitochondria-selective reduction of 62Cu-pyruvaldehyde bis(N4-methylthiosemicarbazone) (62Cu-PTSM) in the murine brain; a novel radiopharmaceutical for brain positron emission tomography (PET) imaging.
Fujibayashi Y; Wada K; Taniuchi H; Yonekura Y; Konishi J; Yokoyama A
Biol Pharm Bull; 1993 Feb; 16(2):146-9. PubMed ID: 8395929
[TBL] [Abstract][Full Text] [Related]
14. Application of the new zinc-62/copper-62 generator: an effective labeling method for 62Cu-PTSM.
Matsumoto K; Fujibayashi Y; Yonekura Y; Wada K; Takemura Y; Konishi J; Yokoyama A
Int J Rad Appl Instrum B; 1992 Jan; 19(1):39-44. PubMed ID: 1577613
[TBL] [Abstract][Full Text] [Related]
15. An improved 62Zn/62Cu generator based on a cation exchanger and its fully remote-controlled preparation for clinical use.
Fukumura T; Okada K; Suzuki H; Nakao R; Mukai K; Szelecsényi F; Kovács Z; Suzuki K
Nucl Med Biol; 2006 Aug; 33(6):821-7. PubMed ID: 16934701
[TBL] [Abstract][Full Text] [Related]
16. In vivo comparison of copper blood-pool agents: potential radiopharmaceuticals for use with copper-62.
Mathias CJ; Welch MJ; Green MA; Diril H; Meares CF; Gropler RJ; Bergmann SR
J Nucl Med; 1991 Mar; 32(3):475-80. PubMed ID: 2005455
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of copper-labeled bifunctional chelate-albumin conjugates for blood pool imaging.
Anderson CJ; Rocque PA; Weinheimer CJ; Welch MJ
Nucl Med Biol; 1993 May; 20(4):461-7. PubMed ID: 8504288
[TBL] [Abstract][Full Text] [Related]
18. Myocardial kinetics of potassium-38 in humans and comparison with copper-62-PTSM.
Melon PG; Brihaye C; Degueldre C; Guillaume M; Czichosz R; Rigo P; Kulbertus HE; Comar D
J Nucl Med; 1994 Jul; 35(7):1116-22. PubMed ID: 8014667
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and evaluation of copper radiopharmaceuticals with mixed bis(thiosemicarbazone) ligands.
Ackerman LJ; West DX; Mathias CJ; Green MA
Nucl Med Biol; 1999 Jul; 26(5):551-4. PubMed ID: 10473194
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of copper(II)-pyruvaldehyde bis (N-4-methylthiosemicarbazone) for tissue blood flow measurement using a trapped tracer model.
Young H; Carnochan P; Zweit J; Babich J; Cherry S; Ott R
Eur J Nucl Med; 1994 Apr; 21(4):336-41. PubMed ID: 8005157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
